Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...

In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.

Most children with multisystem inflammatory syndrome in children recover quickly, according to study findings.

An ejection fraction >35% is unconventional to be considered ... EF ≥40% with diastolic dysfunction evidence on echocardiogram, exercise for ≥3 minutes on treadmill Valsartan titrated to ...

Aims Exercise testing remains underused in patients with aortic stenosis (AS), partly due to concerns about an ...

SMALL heart size is linked to higher mortality risk in individuals with normal ejection fraction , particularly in women and those with high-normal ejection fraction.

Experts warn that this early stage of heart failure, classified as Stage B, often goes unnoticed but can lead to severe ...

The following is a summary of “Reduced antioxidant high-density lipoprotein function in heart failure with preserved ejection ...

AI model transforms heart failure care by precisely identifying cases and enhancing quality evaluations in clinical practice.

Patients with low-gradient aortic stenosis and reduced LVEF, compared with patients with high-gradient aortic stenosis, have worse clinical outcomes.

A new study by researchers at Karolinska Institutet and Södersjukhuset shows that advanced ultrasound imaging analyses cannot ...